Author:
Hwang Paul M.,Bunz Fred,Yu Jian,Rago Carlo,Chan Timothy A.,Murphy Michael P.,Kelso Geoffry F.,Smith Robin A. J.,Kinzler Kenneth W.,Vogelstein Bert
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference39 articles.
1. O'Connor, P.M. et al. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res. 57, 4285–300 (1997).
2. Lowe, S.W. et al. p53 status and the efficacy of cancer therapy in vivo. Science 266, 807–810 (1994).
3. Bunz, F. et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest. 104, 263–269 (1999).
4. Oren, M. Regulation of the p53 tumor suppressor protein. J. Biol. Chem. 274, 36031–36034 (1999).
5. Prives, C. & Hall, P.A. The p53 pathway. J. Pathol. 187, 112–126 (1999).
Cited by
379 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献